nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Alfentanil—ABCB1—ovarian cancer	0.00163	0.732	CrCbGaD
Remifentanil—Immune system disorder—Paclitaxel—ovarian cancer	0.0016	0.00161	CcSEcCtD
Remifentanil—Mediastinal disorder—Paclitaxel—ovarian cancer	0.0016	0.0016	CcSEcCtD
Remifentanil—Chills—Paclitaxel—ovarian cancer	0.00159	0.0016	CcSEcCtD
Remifentanil—Arrhythmia—Paclitaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Remifentanil—Hypersensitivity—Melphalan—ovarian cancer	0.00158	0.00158	CcSEcCtD
Remifentanil—Vomiting—Chlorambucil—ovarian cancer	0.00157	0.00157	CcSEcCtD
Remifentanil—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00155	0.00156	CcSEcCtD
Remifentanil—Pruritus—Topotecan—ovarian cancer	0.00155	0.00155	CcSEcCtD
Remifentanil—Erythema—Paclitaxel—ovarian cancer	0.00155	0.00155	CcSEcCtD
Remifentanil—Feeling abnormal—Vinorelbine—ovarian cancer	0.00155	0.00155	CcSEcCtD
Remifentanil—Renal impairment—Epirubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Remifentanil—Pruritus—Melphalan—ovarian cancer	0.00152	0.00152	CcSEcCtD
Remifentanil—Haemoglobin—Docetaxel—ovarian cancer	0.00151	0.00152	CcSEcCtD
Remifentanil—Haemorrhage—Docetaxel—ovarian cancer	0.0015	0.00151	CcSEcCtD
Remifentanil—Diarrhoea—Topotecan—ovarian cancer	0.0015	0.0015	CcSEcCtD
Remifentanil—Pharyngitis—Docetaxel—ovarian cancer	0.00149	0.0015	CcSEcCtD
Remifentanil—Urticaria—Vinorelbine—ovarian cancer	0.00149	0.00149	CcSEcCtD
Remifentanil—Body temperature increased—Vinorelbine—ovarian cancer	0.00148	0.00149	CcSEcCtD
Remifentanil—Diarrhoea—Melphalan—ovarian cancer	0.00147	0.00147	CcSEcCtD
Remifentanil—Nausea—Chlorambucil—ovarian cancer	0.00146	0.00147	CcSEcCtD
Remifentanil—Visual impairment—Docetaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Remifentanil—Dizziness—Topotecan—ovarian cancer	0.00145	0.00145	CcSEcCtD
Remifentanil—Tremor—Paclitaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Remifentanil—Anaemia—Paclitaxel—ovarian cancer	0.00143	0.00143	CcSEcCtD
Remifentanil—Renal impairment—Doxorubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Remifentanil—Agitation—Paclitaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Remifentanil—Flushing—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Remifentanil—Cardiac disorder—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Remifentanil—Cardiac arrest—Epirubicin—ovarian cancer	0.00139	0.0014	CcSEcCtD
Remifentanil—Vomiting—Topotecan—ovarian cancer	0.00139	0.0014	CcSEcCtD
Remifentanil—Syncope—Paclitaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Remifentanil—Rash—Topotecan—ovarian cancer	0.00138	0.00139	CcSEcCtD
Remifentanil—Hypersensitivity—Vinorelbine—ovarian cancer	0.00138	0.00138	CcSEcCtD
Remifentanil—Dermatitis—Topotecan—ovarian cancer	0.00138	0.00138	CcSEcCtD
Remifentanil—Headache—Topotecan—ovarian cancer	0.00137	0.00138	CcSEcCtD
Remifentanil—Angiopathy—Docetaxel—ovarian cancer	0.00137	0.00137	CcSEcCtD
Remifentanil—Vomiting—Melphalan—ovarian cancer	0.00136	0.00137	CcSEcCtD
Remifentanil—Immune system disorder—Docetaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Remifentanil—Loss of consciousness—Paclitaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Remifentanil—Mediastinal disorder—Docetaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Remifentanil—Rash—Melphalan—ovarian cancer	0.00135	0.00136	CcSEcCtD
Remifentanil—Dermatitis—Melphalan—ovarian cancer	0.00135	0.00135	CcSEcCtD
Remifentanil—Chills—Docetaxel—ovarian cancer	0.00135	0.00135	CcSEcCtD
Remifentanil—Cough—Paclitaxel—ovarian cancer	0.00135	0.00135	CcSEcCtD
Remifentanil—Arrhythmia—Docetaxel—ovarian cancer	0.00134	0.00135	CcSEcCtD
Remifentanil—Convulsion—Paclitaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Remifentanil—Hypokalaemia—Epirubicin—ovarian cancer	0.00134	0.00134	CcSEcCtD
Remifentanil—Hypertension—Paclitaxel—ovarian cancer	0.00133	0.00134	CcSEcCtD
Remifentanil—Pruritus—Vinorelbine—ovarian cancer	0.00133	0.00133	CcSEcCtD
Remifentanil—Nasopharyngitis—Epirubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Remifentanil—Anxiety—Paclitaxel—ovarian cancer	0.00131	0.00131	CcSEcCtD
Remifentanil—Erythema—Docetaxel—ovarian cancer	0.00131	0.00131	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00131	0.00131	CcSEcCtD
Remifentanil—Nausea—Topotecan—ovarian cancer	0.0013	0.0013	CcSEcCtD
Remifentanil—Cardiac arrest—Doxorubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Remifentanil—Dry mouth—Paclitaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Remifentanil—Diarrhoea—Vinorelbine—ovarian cancer	0.00128	0.00129	CcSEcCtD
Remifentanil—Nausea—Melphalan—ovarian cancer	0.00127	0.00128	CcSEcCtD
Remifentanil—Confusional state—Paclitaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Remifentanil—Dysphagia—Epirubicin—ovarian cancer	0.00127	0.00127	CcSEcCtD
Remifentanil—Oedema—Paclitaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Remifentanil—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Remifentanil—Shock—Paclitaxel—ovarian cancer	0.00124	0.00124	CcSEcCtD
Remifentanil—Dizziness—Vinorelbine—ovarian cancer	0.00124	0.00124	CcSEcCtD
Remifentanil—Nervous system disorder—Paclitaxel—ovarian cancer	0.00124	0.00124	CcSEcCtD
Remifentanil—Hypokalaemia—Doxorubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Remifentanil—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00123	0.00124	CcSEcCtD
Remifentanil—Tachycardia—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Remifentanil—Skin disorder—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Remifentanil—Bronchitis—Epirubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Remifentanil—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Remifentanil—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00121	0.00122	CcSEcCtD
Remifentanil—Anaemia—Docetaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Vomiting—Vinorelbine—ovarian cancer	0.00119	0.00119	CcSEcCtD
Remifentanil—Dysuria—Epirubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Remifentanil—Rash—Vinorelbine—ovarian cancer	0.00118	0.00118	CcSEcCtD
Remifentanil—Dermatitis—Vinorelbine—ovarian cancer	0.00118	0.00118	CcSEcCtD
Remifentanil—Hypotension—Paclitaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Remifentanil—Headache—Vinorelbine—ovarian cancer	0.00117	0.00118	CcSEcCtD
Remifentanil—Syncope—Docetaxel—ovarian cancer	0.00117	0.00118	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—ovarian cancer	0.00117	0.00118	CcSEcCtD
Remifentanil—Loss of consciousness—Docetaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Remifentanil—Hyperglycaemia—Epirubicin—ovarian cancer	0.00114	0.00115	CcSEcCtD
Remifentanil—Cough—Docetaxel—ovarian cancer	0.00114	0.00115	CcSEcCtD
Remifentanil—Pneumonia—Epirubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Remifentanil—Convulsion—Docetaxel—ovarian cancer	0.00113	0.00114	CcSEcCtD
Remifentanil—Paraesthesia—Paclitaxel—ovarian cancer	0.00113	0.00114	CcSEcCtD
Remifentanil—Hypertension—Docetaxel—ovarian cancer	0.00113	0.00113	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Remifentanil—Dyspnoea—Paclitaxel—ovarian cancer	0.00112	0.00113	CcSEcCtD
Remifentanil—Somnolence—Paclitaxel—ovarian cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Nausea—Vinorelbine—ovarian cancer	0.00111	0.00112	CcSEcCtD
Remifentanil—Renal failure—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Remifentanil—Dyspepsia—Paclitaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Remifentanil—Dry mouth—Docetaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Remifentanil—Sweating—Epirubicin—ovarian cancer	0.00108	0.00109	CcSEcCtD
Remifentanil—Constipation—Paclitaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Remifentanil—Pain—Paclitaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Remifentanil—Haematuria—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Remifentanil—Confusional state—Docetaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Remifentanil—Oedema—Docetaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Remifentanil—Anaphylactic shock—Docetaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Remifentanil—Shock—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Remifentanil—Nervous system disorder—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Remifentanil—Thrombocytopenia—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Remifentanil—Tachycardia—Docetaxel—ovarian cancer	0.00104	0.00105	CcSEcCtD
Remifentanil—Feeling abnormal—Paclitaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Remifentanil—Skin disorder—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Remifentanil—Bradycardia—Epirubicin—ovarian cancer	0.00103	0.00104	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Remifentanil—Haemoglobin—Epirubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Remifentanil—Haemorrhage—Epirubicin—ovarian cancer	0.00101	0.00102	CcSEcCtD
Remifentanil—Pharyngitis—Epirubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—ovarian cancer	0.001	0.00101	CcSEcCtD
Remifentanil—Urticaria—Paclitaxel—ovarian cancer	0.001	0.001	CcSEcCtD
Remifentanil—Hypotension—Docetaxel—ovarian cancer	0.000999	0.001	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—ovarian cancer	0.000997	0.001	CcSEcCtD
Remifentanil—Body temperature increased—Paclitaxel—ovarian cancer	0.000997	0.000999	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—ovarian cancer	0.000978	0.00098	CcSEcCtD
Remifentanil—Paraesthesia—Docetaxel—ovarian cancer	0.00096	0.000962	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—ovarian cancer	0.000956	0.000958	CcSEcCtD
Remifentanil—Dyspnoea—Docetaxel—ovarian cancer	0.000953	0.000955	CcSEcCtD
Remifentanil—Somnolence—Docetaxel—ovarian cancer	0.00095	0.000952	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—ovarian cancer	0.000944	0.000946	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—ovarian cancer	0.000942	0.000944	CcSEcCtD
Remifentanil—Flushing—Epirubicin—ovarian cancer	0.000942	0.000944	CcSEcCtD
Remifentanil—Dyspepsia—Docetaxel—ovarian cancer	0.000941	0.000943	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—ovarian cancer	0.000939	0.000941	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—ovarian cancer	0.000932	0.000934	CcSEcCtD
Remifentanil—Hypersensitivity—Paclitaxel—ovarian cancer	0.000929	0.000931	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000923	0.000925	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—ovarian cancer	0.000921	0.000923	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—ovarian cancer	0.000917	0.000919	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—ovarian cancer	0.000915	0.000917	CcSEcCtD
Remifentanil—Constipation—Docetaxel—ovarian cancer	0.000914	0.000916	CcSEcCtD
Remifentanil—Pain—Docetaxel—ovarian cancer	0.000914	0.000916	CcSEcCtD
Remifentanil—Chills—Epirubicin—ovarian cancer	0.000911	0.000913	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—ovarian cancer	0.000907	0.000909	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—ovarian cancer	0.000905	0.000907	CcSEcCtD
Remifentanil—Pruritus—Paclitaxel—ovarian cancer	0.000892	0.000894	CcSEcCtD
Remifentanil—Erythema—Epirubicin—ovarian cancer	0.000883	0.000885	CcSEcCtD
Remifentanil—Feeling abnormal—Docetaxel—ovarian cancer	0.000881	0.000883	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—ovarian cancer	0.000872	0.000873	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—ovarian cancer	0.000872	0.000873	CcSEcCtD
Remifentanil—Diarrhoea—Paclitaxel—ovarian cancer	0.000863	0.000865	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—ovarian cancer	0.000852	0.000854	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—ovarian cancer	0.000848	0.00085	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000846	0.000848	CcSEcCtD
Remifentanil—Body temperature increased—Docetaxel—ovarian cancer	0.000845	0.000847	CcSEcCtD
Remifentanil—Chills—Doxorubicin—ovarian cancer	0.000843	0.000844	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—ovarian cancer	0.000839	0.000841	CcSEcCtD
Remifentanil—Dizziness—Paclitaxel—ovarian cancer	0.000834	0.000836	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—ovarian cancer	0.000817	0.000819	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—ovarian cancer	0.000817	0.000818	CcSEcCtD
Remifentanil—Agitation—Epirubicin—ovarian cancer	0.000812	0.000814	CcSEcCtD
Remifentanil—Vomiting—Paclitaxel—ovarian cancer	0.000802	0.000804	CcSEcCtD
Remifentanil—Rash—Paclitaxel—ovarian cancer	0.000795	0.000797	CcSEcCtD
Remifentanil—Dermatitis—Paclitaxel—ovarian cancer	0.000794	0.000796	CcSEcCtD
Remifentanil—Syncope—Epirubicin—ovarian cancer	0.000792	0.000794	CcSEcCtD
Remifentanil—Headache—Paclitaxel—ovarian cancer	0.00079	0.000792	CcSEcCtD
Remifentanil—Hypersensitivity—Docetaxel—ovarian cancer	0.000788	0.000789	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—ovarian cancer	0.000777	0.000778	CcSEcCtD
Remifentanil—Cough—Epirubicin—ovarian cancer	0.000771	0.000773	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—ovarian cancer	0.000765	0.000767	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—ovarian cancer	0.000763	0.000764	CcSEcCtD
Remifentanil—Pruritus—Docetaxel—ovarian cancer	0.000756	0.000758	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—ovarian cancer	0.000756	0.000757	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—ovarian cancer	0.000751	0.000753	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—ovarian cancer	0.00075	0.000751	CcSEcCtD
Remifentanil—Nausea—Paclitaxel—ovarian cancer	0.000749	0.000751	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000747	0.000749	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—ovarian cancer	0.000736	0.000737	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—ovarian cancer	0.000733	0.000735	CcSEcCtD
Remifentanil—Diarrhoea—Docetaxel—ovarian cancer	0.000731	0.000733	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—ovarian cancer	0.000727	0.000729	CcSEcCtD
Remifentanil—Oedema—Epirubicin—ovarian cancer	0.000721	0.000723	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—ovarian cancer	0.000721	0.000723	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—ovarian cancer	0.000718	0.00072	CcSEcCtD
Remifentanil—Cough—Doxorubicin—ovarian cancer	0.000713	0.000715	CcSEcCtD
Remifentanil—Shock—Epirubicin—ovarian cancer	0.000709	0.000711	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—ovarian cancer	0.000708	0.00071	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—ovarian cancer	0.000707	0.000709	CcSEcCtD
Remifentanil—Dizziness—Docetaxel—ovarian cancer	0.000707	0.000708	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—ovarian cancer	0.000706	0.000708	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—ovarian cancer	0.000706	0.000707	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—ovarian cancer	0.000704	0.000705	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—ovarian cancer	0.0007	0.000702	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—ovarian cancer	0.000697	0.000699	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—ovarian cancer	0.000694	0.000695	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000691	0.000693	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—ovarian cancer	0.000681	0.000682	CcSEcCtD
Remifentanil—Vomiting—Docetaxel—ovarian cancer	0.00068	0.000681	CcSEcCtD
Remifentanil—Rash—Docetaxel—ovarian cancer	0.000674	0.000676	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—ovarian cancer	0.000674	0.000675	CcSEcCtD
Remifentanil—Dermatitis—Docetaxel—ovarian cancer	0.000673	0.000675	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—ovarian cancer	0.000673	0.000674	CcSEcCtD
Remifentanil—Headache—Docetaxel—ovarian cancer	0.00067	0.000671	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—ovarian cancer	0.000667	0.000669	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000667	0.000669	CcSEcCtD
Remifentanil—Shock—Doxorubicin—ovarian cancer	0.000656	0.000658	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—ovarian cancer	0.000654	0.000656	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000653	0.000655	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—ovarian cancer	0.000651	0.000653	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—ovarian cancer	0.000648	0.000649	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—ovarian cancer	0.000647	0.000649	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000645	0.000646	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—ovarian cancer	0.000643	0.000644	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—ovarian cancer	0.000641	0.000642	CcSEcCtD
Remifentanil—Nausea—Docetaxel—ovarian cancer	0.000635	0.000636	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—ovarian cancer	0.000635	0.000636	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—ovarian cancer	0.000623	0.000625	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000622	0.000624	CcSEcCtD
Remifentanil—Pain—Epirubicin—ovarian cancer	0.000617	0.000618	CcSEcCtD
Remifentanil—Constipation—Epirubicin—ovarian cancer	0.000617	0.000618	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—ovarian cancer	0.000599	0.0006	CcSEcCtD
Remifentanil—Fentanyl—ABCB1—ovarian cancer	0.000595	0.268	CrCbGaD
Remifentanil—Dyspnoea—Doxorubicin—ovarian cancer	0.000595	0.000596	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—ovarian cancer	0.000594	0.000595	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—ovarian cancer	0.000593	0.000594	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—ovarian cancer	0.000587	0.000589	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000576	0.000577	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—ovarian cancer	0.000573	0.000574	CcSEcCtD
Remifentanil—Pain—Doxorubicin—ovarian cancer	0.000571	0.000572	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—ovarian cancer	0.000571	0.000572	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—ovarian cancer	0.00057	0.000571	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—ovarian cancer	0.00055	0.000551	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—ovarian cancer	0.000531	0.000532	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—ovarian cancer	0.00053	0.000531	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—ovarian cancer	0.000527	0.000529	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—ovarian cancer	0.00051	0.000511	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—ovarian cancer	0.000493	0.000494	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—ovarian cancer	0.000492	0.000493	CcSEcCtD
Remifentanil—Dizziness—Epirubicin—ovarian cancer	0.000477	0.000478	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—ovarian cancer	0.000472	0.000473	CcSEcCtD
Remifentanil—Vomiting—Epirubicin—ovarian cancer	0.000458	0.000459	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—ovarian cancer	0.000456	0.000457	CcSEcCtD
Remifentanil—Rash—Epirubicin—ovarian cancer	0.000455	0.000456	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—ovarian cancer	0.000454	0.000455	CcSEcCtD
Remifentanil—Headache—Epirubicin—ovarian cancer	0.000452	0.000453	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—ovarian cancer	0.000441	0.000442	CcSEcCtD
Remifentanil—Nausea—Epirubicin—ovarian cancer	0.000428	0.000429	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—ovarian cancer	0.000424	0.000425	CcSEcCtD
Remifentanil—Rash—Doxorubicin—ovarian cancer	0.000421	0.000422	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—ovarian cancer	0.00042	0.000421	CcSEcCtD
Remifentanil—Headache—Doxorubicin—ovarian cancer	0.000418	0.000419	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—ovarian cancer	0.000396	0.000397	CcSEcCtD
